NFKB1 and cancer: These findings improve our understanding of F. nucleatum’s involvement in CRC and may guide the development of immunomodulatory therapies targeting macrophage reprogramming or NF-κB pathways, potentially enhancing outcomes in pathogen-associated cancers.